Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
86
days
Preclinical evaluation of a CD137-targeted PET tracer for detection of inflammatory arthritis
Authors
Luna Ge; Shuxian Zhou; Binbin Ding; Mengjie Bai; Yuang Zhang; Jihong Pan; Lin Wang; Yongpeng Ge; Kai ChengShow moreShow less
Affiliations
Biomedical Sciences College and Shandong Medicinal Biotechnology Centre, Key lab for Biotech-Drugs of National Health Commission, Key Lab for Genetic Engineering and Synthetic Biology of Shandong Province, Ji'nan, 250117, China; Neck, Shoulder, Waist and Leg Pain Hospital of Shandong First Medical University, Ji'nan, Shandong, 250117, China; Department of Rheumatology, China-Japan Friendship Hospital, Beijing, 100029, China; Center for Nuclear Medicine and Molecular Imaging, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, ChinaShow moreShow less
70
days
Integrated [68Ga]Ga-FAPI-7ND PET/CT and stromal profiling of immunocompetent syngeneic tumor models for FAP-targeted radionuclide therapy
Authors
Huijie Li; Yuling Zhang; Xin Ren; Chenyue Liu; Lexing Zhang; Yuanbo Wang; Wei Qiang; Shuai Jiao; Qianqian Geng; Rui GaoShow moreShow less
Affiliations
Department of Nuclear Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, 277W Yanta Road, Xi'an, Shaanxi, 710061, ChinaShow moreShow less
54
days
cGMP production of radiometal solutions from solid targets at a university-scale facility
Authors
Aidan Bender; Brock Mower; Brandon Buckway; Jeffrey YapShow moreShow less
Affiliations
Center for Quantitative Cancer Imaging and Therapy, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA; Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, 84112, USA; Sego Therapeutics, Salt Lake City, UT, 84102, USA; Department of Radiology and Imaging Science, University of Utah, Salt Lake City, UT, 84112, USAShow moreShow less
112
days
FAP-targeted [177Lu]Lu-FAP-2286 radioligand therapy synergizes with the STING agonist diABZI to enhance antitumor immunity in lung cancer
Authors
Jiahao Xie; Yijin Zou; Dazhi Shi; Yuhao Huang; Wenlan Zhou; Ying Tian; Meng Wang; Pei Han; Hubing Wu; Lijuan WangShow moreShow less
Affiliations
Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China; Department of Nuclear Medicine, Guangzhou Universal Medical Imaging Diagnostic Center, Guangzhou City, Guangdong Province, ChinaShow moreShow less
65
days
Exploration of the cysteine protease trapping approach to prolong tumor retention of antifolate targeted radionuclide therapeutics
Authors
Sadie Klein; Audifás-Salvador Matus-Meza; Julian M. Klein; Pedram Rikhtechi; Katie Brake; Daniel Carlson; Kiana Sherkat Sadi; Erika A. Cone; Tobin Shea; Jered C. GarrisonShow moreShow less
Affiliations
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, 68105, United States; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68105, United States; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68105, United States; Department of Biomedical Science, Creighton University, Omaha, NE, 68178, United States; Center for Drug Delivery and Nanomedicine, University of Nebraska Medical Center, Omaha, NE, 68105, United StatesShow moreShow less
187
days
Translational imaging evidence for rapid reversal of amyloid and myelin pathology following deep cervical lymphatic–venous anastomosis in Alzheimer's disease
Authors
Xu Wang; Yongtao Liu; Jinxiang Liu; Rongyi Wang; Jing Zheng; Zhiyang Deng; Kunxiu Song; Daijie Zhang; Chunwei Wang; Kai Zhu; Jinming Zhang; Chunying Wu; Guige Hou; Erik F.J. de Vries; Yanming WangShow moreShow less
Affiliations
Institute of Nuclear Medicine and Molecular Imaging, Shandong Medical and Pharmaceutical University Hospital, Binzhou, 256603, China; Department of Nuclear Medicine, Shandong Medical and Pharmaceutical University Hospital, Binzhou, 256603, China; Department of Microsurgery, Shandong Medical and Pharmaceutical University Hospital, Binzhou, 256603, China; Department of Nuclear Medicine, PLA General Hospital, Beijing, 100039, China; School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA; School of Pharmacy, Shandong Medical and Pharmaceutical University, Yantai, 264003, China; Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Binzhou Institute of Technology, Weiqiao-UCAS Science and Technology Park, Binzhou, ChinaShow moreShow less
FAQ
How long does NUCLEAR MEDICINE AND BIOLOGY take to review a manuscript?
As of 2026-11-19, CrushSCI has 15 complete review records for NUCLEAR MEDICINE AND BIOLOGY. The fastest paper went from submission to acceptance in 54 days (cGMP production of radiometal solutions from solid targets at a university-scale facility, received 2026-08-13, accepted 2026-10-06); the slowest took 187 days. The average is 109.9 days and the median is 111 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
